Start of a new bull market for 2023 or a bear market rally?

Marc Kennis Marc Kennis, November 14, 2022

Bear market rally, or start of a bull market?

Stuart Roberts from Pitt Street Research says its the start of a bull market. He cites the central banks tightening interest rates, a response from pricing and the global economy returning to normal. Stuart still backs Medibank, who didn’t pay the hackers ransom, and he thinks this will result in an interesting investor response and people should watch it carefully.

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

Turning to the Star Entertainment Group, Stuart says the worst that can happen is the regulator takes away their licenses, but this didn’t happen in NSW. He says the casinos are imporant tourist attractions and the markets aren’t currently pricing in any of the upsides to Star as the post-Covid economy returns to normal. Star also has a new CEO with elaborate plans to clean house. And Medibank will probably also do well in a new bull market.

Watch the entire Ausbiz interview here!

 

 

No time to do stock research, but you still want to invest?
 
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!

 

GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY

 

No credit card needed and the trial expires automatically.

 

 

 

 

 

Blog Categories

Get Our Top 5 ASX Stocks for FY25

Recent Posts

Findi (ASX:FND): Its quadrupled in 12 months off the back of financial services in India

Until Findi (ASX:FND) came along, there were practically no ASX companies making money from India (or at least not many…

ASX Listing Rules

Here are 5 key ASX Listing Rules that investors need to know about!

All companies listed on the ASX need to know about the ASX Listing Rules. The reason is obvious: Because there’s…

ASX stocks fighting diabetes

Here are 3 ASX stocks fighting diabetes and the opportunity ahead of them

There aren’t many ASX stocks fighting diabetes, but the few that are have a big market opportunity ahead of them. And…